Step-wise management of anaemia in people with chronic kidney disease in primary care: qualitative study

Abstract Background Anaemia is common in chronic kidney disease (CKD). It is associated with increased cardiovascular risk and reduced quality of life, but is often sub-optimally managed. Most patients are managed in primary care alongside other comorbidities. Interventions to improve the management of anaemia in CKD in this setting are needed.MethodsWe conducted a qualitative study to evaluate how an audit-based education (ABE) intervention might improve the management of anaemia in CKD. We explored outcomes that would be relevant to practitioners and patients, that exposed variation of practice from National Institute for Health and Care Excellence (NICE) guidelines, and whether the intervention was feasible and acceptable. ResultsPractitioners (n=5 groups) and patients (n=7) from four London general practices participated in discussions. Practitioners welcomed the evidence-based step-wise intervention. However, prescribing erythropoiesis-stimulating agents (ESAs) was felt to be outside of their scope of practice. There was a gap between NICE guidance and clinical practice in primary care. Iron studies were not well understood and anaemia management was often conservative or delayed. Patients were often unaware of having CKD, and were more concerned about their other comorbidities, but largely trusted their GPs to manage them appropriately. ConclusionsThe first steps of the intervention were welcomed by practitioners, but they expressed concerns about independently prescribing ESAs. Renal physicians and GPs could develop shared care protocols for ESA use in primary care. There is scope to improve awareness of renal anaemia, and enhance knowledge of guideline recommendations; and our intervention should be modified accordingly.